The Preventing Illegal Laboratories and Protecting Public Health Act of 2025 requires distributors of dangerous pathogens to maintain detailed electronic logbooks tracking all sales, loans, and transfers of highly pathogenic agents—such as disease-causing organisms classified as risk group 3 or higher. Distributors must record buyer information, intended use, storage location, and require buyers to present government-issued photo identification and sign the logbook, with false statements subject to federal criminal penalties. The bill affects any entity selling or distributing these pathogens, including biobanks and repositories, and requires logbooks be retained for three years. Additionally, the legislation directs federal agencies to conduct a strategic evaluation of high-containment laboratories nationwide, develop national safety standards, establish a federal contact point for state and local officials on laboratory biosafety issues, and study the feasibility of creating a database of high-containment labs accessible to federal and state authorities. These evaluations and the biosafety team must be completed within one year of implementation, with findings reported to Congress.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.